These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14132244)

  • 1. [TRIACETYLOLEANDOMYCIN. TREATMENT OF CUTANEOUS INFECTIONS IN CHILDREN. (APROPOS OF 42 CASES)].
    CORCOS V
    Clinique (Paris); 1964 Jan; 59():61-6. PubMed ID: 14132244
    [No Abstract]   [Full Text] [Related]  

  • 2. Triacetyloleandomycin in the treatment of severe infections in infants and children.
    OZYAZICI A; COHEN HJ; PRIGOT A
    Q Rev Pediatr; 1960; 15():102-9. PubMed ID: 14429613
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial of triacetyloleandomycin in the treatment of acne conglobata, nummular dermatitis and other resistant coccogenous dermatologic infections.
    KLESSENS NF
    Antibiot Chemother (Northfield); 1962 Aug; 12():551-3. PubMed ID: 14456900
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythromycin, oleandomycin and triacetyloleandomycin.
    Ross S
    Pediatr Clin North Am; 1968 Feb; 15(1):119-29. PubMed ID: 4867776
    [No Abstract]   [Full Text] [Related]  

  • 5. Oleandomycin and triacetyloleandomycin.
    FOLTZ EL
    Pediatr Clin North Am; 1961 Nov; 8():1133-42. PubMed ID: 13893869
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacteriostatic activity exhibited by oleandomycin, triacetyl oleandomycin and spiramycin on mycobacteria].
    VIALLIER J; AUGAGNEUR J
    C R Seances Soc Biol Fil; 1962; 156():1435-7. PubMed ID: 13997027
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of triacetyloleandomycin in skin and soft tissue infections: results of a New Zealand general-practitioner multi-centre trial.
    Vaughan GP; Vaughan AM
    N Z Med J; 1977 Oct; 86(598):385-6. PubMed ID: 305017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of triacetyloleandomycin in general infections of institutionalized patients.
    CARTER CH
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():125-8. PubMed ID: 13808017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic trial of triacetyloleandomycin (TAO) in infections caused by gram-positive bacteria and Klebsiella].
    KRALJEVIC R; BORGONO JM; VILLALOBOS M; MENDOZA A
    Rev Med Chil; 1960 Aug; 88():644-7. PubMed ID: 13753910
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new anti-staphylococcal agent of value: triacetyloleandomycin. Results of the treatment of various staphylococcias by triacetyloleandomycin in hospital milieu].
    KOSKAS R; ZIRAH P
    Tunis Med; 1961; 39():615-26. PubMed ID: 14458647
    [No Abstract]   [Full Text] [Related]  

  • 11. The challenge of triacetyloleandomycin in pediatric infections.
    NEWSOME CK
    J Indiana State Med Assoc; 1960 Jun; 53():1131-3. PubMed ID: 14426838
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of triacetyloleandomycin on bacterial infections of the respiratory tract.
    WAREMBOURG H
    Antibiot Annu; 1959-1960; 7():816-8. PubMed ID: 13842895
    [No Abstract]   [Full Text] [Related]  

  • 13. Triacetyloleandomycin: a report on its use in a general hospital.
    LEFEBVRE M; BELIVEAU D; DESILETS R; SIMARD J; CHARBONNEAU PE; LAFORTUNE L; ROY J
    Antibiot Annu; 1959-1960; 7():755-60. PubMed ID: 14415263
    [No Abstract]   [Full Text] [Related]  

  • 14. [MICROBIOLOGICAL STUDIES ON TRIACETYLOLEANDOMYCIN].
    VAKULENKO NA
    Antibiotiki; 1964 Nov; 9():1017-20. PubMed ID: 14320473
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid diagnostic susceptibility tests and prompt therapy with triacetyloleandomycin.
    RIPBERGER FM; ANDERSON RH; PALMER RE
    Antibiotic Med Clin Ther (New York); 1959 Nov; 6():662-9. PubMed ID: 14437535
    [No Abstract]   [Full Text] [Related]  

  • 16. Generalized eruption from triacetyloleandomycin.
    WELSH AL; EDE M
    Antibiotic Med Clin Ther (New York); 1960 Mar; 7():179-81. PubMed ID: 13843917
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with the antibiotic triacetyloleandomycin and the combination preparation tetracycline-oleandomycin in childhood].
    DIETEL V; MEISSNER F
    Dtsch Gesundheitsw; 1961 Dec; 16():2470-4. PubMed ID: 13886293
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of triacetyloleandomycin in treatment of infected acne.
    EDELSTEIN AJ
    Pa Med J; 1962 Feb; 65():188-90. PubMed ID: 13889160
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood concentrations of oleandomycin after administration of triacetyloleandomycin].
    Caliò R; Pezzi R; Renzini G
    Gazz Int Med Chir; 1964 Dec; 68(24):Suppl:2540-7. PubMed ID: 5294274
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholestatic hepatitis caused by esters of erythromycin and oleandomycin.
    GILBERT FI
    JAMA; 1962 Dec; 182():1048-50. PubMed ID: 13947810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.